Glendon Johnson - IVH Independent Trustee
| IVH Etf | USD 11.18 0.00 0.00% |
Mr. Glendon E. Johnson, Jr., serves as an Independent Trustee of the Company. Mr. Johnson practiced law for over 30 years, specializing in corporate finance, securities and mergers and acquisitions, including representing and advising financial services companies and investment advisers and their boards. In addition, for over twelve years, he was involved in the acquisition, sale, financing, and daily business affairs of several financial service companies, including investment managers. He serves as a Director of the Thomas Foundation for Cancer Research
| Age | 68 |
| Tenure | 11 years |
| Phone | 215-255-1200 |
| Web | https://www.ivyfunds.com/products-performance/mutual-funds/ivy-closed-end-funds/high-income-opportunities/991 |
Glendon Johnson Latest Insider Activity
Tracking and analyzing the buying and selling activities of Glendon Johnson against IVH etf is an integral part of due diligence when investing in IVH. Glendon Johnson insider activity provides valuable insight into whether IVH is net buyers or sellers over its current business cycle. Note, IVH insiders must abide by specific rules, including filing SEC forms every time they buy or sell IVH'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Glendon Johnson over a week ago Disposition of tradable shares by Glendon Johnson of IVH subject to Rule 16b-3 |
Similar Fund Executives
| Showing other executives | One Year Return | ||
| Michael Holland | Blackstone Gso Long | 76 | |
| Susan JD | Northern Trust | 66 | |
| Charles Park | Blackrock Debt Strategies | 54 | |
| Fred Ricciardi | Pioneer Floating Rate | 72 | |
| Bradford Gallagher | Allianzgi Convertible Income | 75 | |
| Thomas Jasper | Blackstone Gso Strategic | 72 | |
| Robert Frenkel | Western Asset Investment | 66 | |
| Thomas South | Northern Trust | 52 | |
| Jonathan Chirunga | Pioneer Municipal High | N/A | |
| Michael Castellano | BlackRock Floating Rate | 75 | |
| Catherine Lynch | BlackRock Municipal Income | 60 | |
| Thomas Harter | Allianzgi Convertible Income | 45 | |
| Charles Park | BlackRock Municipal Income | 57 | |
| Patrick Mahoney | Northern Trust | N/A | |
| David Johnson | Pioneer Floating Rate | 39 | |
| Frank Fabozzi | BlackRock Municipal Income | 73 | |
| Robert Hubbard | Blackrock Debt Strategies | 63 | |
| Judith Stockdale | Nuveen Global High | 74 | |
| Thomas Faust | Eaton Vance Senior | 63 | |
| Carole Stone | Nuveen Global High | 74 | |
| Kelly ODonnell | Pioneer Floating Rate | 48 | |
IVH Money Managers
| Daniel Geatens, Senior Vice President Treasurer | ||
| Richard Salus, Chief Financial Officer, Senior Vice President | ||
| Philip Shipp, Assistant Secretary | ||
| James Gressett, Independent Trustee | ||
| Christianna Wood, Independent Trustee | ||
| James Concannon, independent trustee | ||
| Jerome Abernathy, Independent Trustee | ||
| Joseph Kauten, Principal Financial Officer, Principal Accounting Officer, Vice President Treasurer | ||
| Michael Smith, Independent Trustee | ||
| John Fry, Independent Trustee | ||
| Sandra Lawrence, Independent Trustee | ||
| H Dobbs, Independent Trustee | ||
| Scott Schneider, Chief Compliance Officer, Vice President | ||
| Thomas Whitford, Independent Trustee | ||
| David Connor, Senior Vice President General Counsel, Secretary | ||
| Edward Tighe, Independent Trustee | ||
| Ann Borowiec, Independent Trustee | ||
| Joseph Chow, Independent Trustee | ||
| Frank Ross, independent trustee | ||
| Shawn Lytle, President, Chief Executive Officer, Trustee | ||
| Jennifer Dulski, Secretary | ||
| Frances SevillaSacasa, Independent Trustee | ||
| Janet Yeomans, Independent Trustee | ||
| Glendon Johnson, Independent Trustee | ||
| Joseph Harroz, Independent Chairman of the Board of Trustees | ||
| Thomas Bennett, Independent Chairman of Board of Trustees | ||
| Henry Herrmann, President Trustee | ||
| Philip Sanders, President, Trustee |
IVH Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is IVH a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Shares Outstanding | 16.57 M | |||
| Shares Owned By Institutions | 53.69 % | |||
| Number Of Shares Shorted | 19.34 K | |||
| Price To Earning | 208.40 X | |||
| Short Ratio | 0.38 X | |||
| Earnings Per Share | 0.05 X | |||
| Number Of Employees | 13 | |||
| Beta | 0.51 | |||
| Market Capitalization | 178.71 M | |||
| Five Year Return | 8.77 % |
Currently Active Assets on Macroaxis
When determining whether IVH offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IVH's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ivh Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Ivh Etf:Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
The market value of IVH is measured differently than its book value, which is the value of IVH that is recorded on the company's balance sheet. Investors also form their own opinion of IVH's value that differs from its market value or its book value, called intrinsic value, which is IVH's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IVH's market value can be influenced by many factors that don't directly affect IVH's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IVH's value and its price as these two are different measures arrived at by different means. Investors typically determine if IVH is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IVH's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.